Sociodemographic Determinants of Waitlist and Posttransplant Survival Among End-Stage Liver Disease Patients
- Registration Closed
Practice Gap
End stage liver disease patient mortality is predominantly considered in terms of biochemical
parameters, as measured by the MELD score, and access to transplant, as measured by
relative number of organ donors. In this report, we illustrate how inclusion of sociodemographic
factors affecting mortality risk could change inform liver transplant care and policy.
Learner Objectives
As a result of participating in this activity, participants will be able to:
1. Identify disadvantaged populations, as measured by two risk indices
2. Inform patients and caregivers of risk inherent to being in these populations
3. Understand how inclusion of these factors changes discussions of need and access in liver
transplantation.
Accreditation
The American Society of Transplant Surgeons (ASTS) is accredited by the
Accreditation Council for Continuing Medical Education to provide continuing medical education
for physicians.
ASTS designates this enduring material activity for a maximum of 1.0 AMA
PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of
their participation in the activity.
Activity Disclosures
None of the authors, planners, staff or CME committee members for this activity had any
relevant financial relationships with commercial interests to disclose.
Instructions for completing ASTS MOC – Education through AJT modules
*Please note, you must hit the “next” icon after each step in the AJT MOC module
1. Review article.
2. Complete post-test. A passing score of 75% is required to move forward. The test can
be retaken as many times as necessary.
3. Complete the evaluation.
4. Access your AJT MOC certificate(s) and transcript of modules completed under the “My
Learning” tab.